Tobacco plants used to develop new rabies treatment

02/3/2013 | News-Medical.Net

In an attempt to create a more cost-effective treatment for people in impoverished countries who are infected with the rabies virus, researchers in London developed a monoclonal antibody to rabies using leaves of the tobacco plant. The antibody blocks the virus from adhering to nerve endings at the site of the initial bite. "An untreated rabies infection is nearly 100% fatal and is usually seen as a death sentence. Producing an inexpensive antibody in transgenic plants opens the prospect of adequate rabies prevention for low-income families in developing countries," said researcher Leonard Both.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA